Cited by 196Inflammatory Bowel DiseaseHealth Systems, Economic Evaluations, Quality of LifeMusculoskeletal pain and rehabilitation

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn’s disease

Reilly, Margaret C., Gerlier, Laetitia, Brabant, Yves, Brown, Martin·2008·Clinical Therapeutics

DOI 10.1016/j.clinthera.2008.02.016

Open this paper in CoChat — free account

Abstract

Background Crohn's disease (CD) is a chronic inflammatory bowel disease usually diagnosed in early adult life and characterized by unpredictable flares and debilitating symptoms such as diarrhea, abdominal pain, and fever, which can interfere with a patient's ability to work and perform daily activities.Objective The aim of this study was to assess the validity, reliability, and responsiveness of the Work Productivity and Activity Impairment questionnaire in CD (WPAI:CD).Methods The WPAI:CD was tested in CD patients enrolled in a 26-week randomized clinical trial of cer-tolizumab pegol versus placebo. Discriminative validity of WPAI:CD absenteeism, presenteeism(reduced on-the-job effectiveness), overall work productivity loss (absenteeism + presenteeism), and activity impairment scores was assessed relative to 5 measures of disease severity and health status: CD Activity Index (CDAI), Short Form-36 physical component summary (PCS) and mental health component summary (MCS) scores, Inflammatory Bowel Disease Questionnaire (IBDQ), and the 5-dimensional EuroQoL health-related quality-of-life visual analog scale (EQ-VAS). Responsiveness was assessed by comparing changes in WPAI:CD scores from baseline to week 26 for patients in remission (CDAI <150 points) versus no remission. Standardized Response Means (SRMs) were calculated to evaluate the magnitude of the changes.Results A total of 662 patients (mean [range] age, 37.4 [18-77] years; male, 288 [43.5%]; white, 629 [95.0%]) were enrolled in the study. Patients with CD of the worst severity (CDAI > median) showed significantly higher impairment in work (+10.5%) and activities (+10.4%) versus patients with "best health" (no problems) (both, P < or = 0.001). Patients with "worst" IBDQ, PCS, MCS, and EQ-VAS scores also showed significantly higher impairments in work (IBDQ, VAS -24.2%; PCS, -24.1%; MCS, -15.9%; EQ-VAS, -16.5%) and activities (IBDQ, -23.3%; PCS, -21.8%; MCS, -16.5%; EQ-VAS, -17.2%) versus "best" scores (all, P < 0.05). There were significant differences between WPAI:CD impairment scores for patients in remission versus patients failing to achieve remission (P < 0.05). SRMs were small (ie, <0.5) in the nonre-mission group, and moderate to large (ie, >0.5) for patients in remission.Conclusions The discriminative validity, reliability, and responsiveness of the WPAI:CD were demonstrated. The WPAI:CD may be useful for evaluating drug impact on CD.

Integrity signals

Registry

Crossref · 10.1016/j.clinthera.2008.02.016

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
Self-citation
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Assche, G. V., Dignass, A. U., Panés, J., Beaugerie, L., Karagiannis, J. A., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E. J., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,444
A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease
Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R. L., & Tompkins, C. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80080-0 · Cited by 1,289
Certolizumab Pegol for the Treatment of Crohn's Disease
Sandborn, W. J., Feagan, B. G., Stoinov, S., Honiball, P., Rutgeerts, P. J., Mason, D. H., Bloomfield, R., & Schreiber, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067594 · Cited by 1,141
Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
Irvine, E. J., Feagan, B. G., Rochon, J., Archambault, A., Fedorak, R. N., Groll, A., Kinnear, D. G., Saibil, F. G., & McDonald, J. W. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90585-1 · Cited by 709
Update on the incidence and prevalence of Crohnʼs disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000
Loftus, C. G., Loftus, E. V., Harmsen, S. W., Zinsmeister, A. R., Tremaine, W. J., Melton, J. L., & Sandborn, W. J. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20029 · Cited by 638
European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis
Stange, E. F., Travis, S. P. L., Vermeire, S., Beglinger, C., Kupcinkas, L., Geboes, K., Barakauskiene, A., Villanacci, V., Herbay, A. V., Warren, B. F., et al. (2006) · Gut · doi:10.1136/gut.2005.081950a · Cited by 506
Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process
For the European Regulatory Issues on Quality of Life Assessment Group, Chassany, O., Sagnier, P., Marquis, P., Fullerton, S., & Aaronson, N. K. (2002) · Drug Information Journal · doi:10.1177/009286150203600127 · Cited by 366

Show all 41 references

Research works printed but not linked: 4

Ekbom, 1998, Cost to society of Crohn's disease, Res Clin Forums, 20, 33
Joshua-Gotlib, 2004, Evaluation of the burden of illness in patients with mild to moderate Crohn disease, Drug Benefit Trends, 16, 600
Wahlqvist, 2003, Resolution of upper gastrointestinal symptoms associated with chronic non-steroidal anti-inflammatory drug therapy has a positive impact on patient-reported productivity, Gastroenterology, 124, A107
2000, EQ-5D: A measure of heath-related quality of life developed by the EuroQol Group: User guide, EuroQol Group

Sorted by citations

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Peyrin‐Biroulet, L., Sandborn, W. J., Sands, B. E., Reinisch, W., Bemelman, W. A., Bryant, R. V., D’Haens, G., Dotan, I., Dubinsky, M. C., Feagan, B. G., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,902
Certolizumab Pegol for the Treatment of Crohn's Disease
Sandborn, W. J., Feagan, B. G., Stoinov, S., Honiball, P., Rutgeerts, P. J., Mason, D. H., Bloomfield, R., & Schreiber, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067594 · Cited by 1,141
Validity of the work productivity and activity impairment questionnaire—general health version in patients with rheumatoid arthritis
Zhang, W., Bansback, N., Boonen, A., Young, A., Singh, A., & Anis, A. H. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3141 · Cited by 287
Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity
Fourquet, J., Báez, L., Figueroa, M., Iriarte, R. I., & Flores, I. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.095 · Cited by 262
“Impact on health, work productivity, and daily life activities has been already described by qualitative studies (16-20) and costs of productivity loss has been estimated (21).”
Background
Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease
Williet, N., Sandborn, W. J., & Peyrin–Biroulet, L. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.016 · Cited by 260
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Colombel, J., Rutgeerts, P. J., Sandborn, W. J., Yang, M., Camez, A. A., Pollack, P. F., Thakkar, R. B., Robinson, A. M., Chen, N., Mulani, P. M., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.06.019 · Cited by 244
Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis
Reilly, M. C., Gooch, K. L., Wong, R. L., Kupper, H., & van der Heijde, D. (2010) · Rheumatology · doi:10.1093/rheumatology/kep457 · Cited by 242
Self-citation
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
Lichtiger, S., Binion, D. G., Wolf, D. C., Present, D. H., Bensimon, A. G., Wu, E. Q., Yu, A. P., Cardoso, A. T., Chao, J., Mulani, P. M., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04466.x · Cited by 185
The prevalence, correlates and treatment of pain in the European Union
Langley, P. C. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.542136 · Cited by 184
Fatigue is highly associated with poor health‐related quality of life, disability and depression in newly‐diagnosed patients with inflammatory bowel disease, independent of disease activity
Cohen, B. L., Zoëga, H., Shah, S. A., LeLeiko, N. S., Lidofsky, S., Bright, R., Flowers, N. T., Law, M. M., Moniz, H., Merrick, M., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12659 · Cited by 175
Work Productivity in Relapsing Multiple Sclerosis: Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life
Glanz, B. I., Degano, I. R., Rintell, D. J., Chitnis, T., Weiner, H. L., & Healy, B. C. (2012) · Value in Health · doi:10.1016/j.jval.2012.07.010 · Cited by 170
Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients
Williet, N., Sarter, H., Gower‐Rousseau, C., Adrianjafy, C., Olympie, A., Buisson, A., Beaugerie, L., & Peyrin‐Biroulet, L. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw145 · Cited by 162
The Burden of Inflammatory Bowel Disease
Devlen, J., Beusterien, K. M., Yen, L., Ahmed, A., Cheifetz, A. S., & Moss, A. C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000440983.86659.81 · Cited by 142
The impact of pain on labor force participation, absenteeism and presenteeism in the European Union
Langley, P. C., Müller-Schwefe, G. H. H., Nicolaou, A., Liedgens, H., Pergolizzi, J. V., & Varrassi, G. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.529379 · Cited by 128
The prevalence, correlates and treatment of pain in Spain
Langley, P. C., Ibán, M. Á. R., Molina, J. T., Andrés, J. A. D., & González-Escalada, J. R. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.583303 · Cited by 107
eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in C rohn's disease
Pedersen, N. K., Elkjær, M., Ďuricová, D., Burisch, J. M., Dobrzanski, C., Andersen, N. N., Jess, T., Bendtsen, F., Langholz, E., Leotta, S., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12043 · Cited by 100
Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil
Parra, R. S., Chebli, J. M., Amarante, H. M., Flores, C., Parente, J. M., Ramos, O., Fernandes, M., Rocha, J. J., Feitosa, M. R., Feres, O., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i38.5862 · Cited by 92
Impact of Age, Sex, Physical Function, Health-related Quality of Life, and Treatment with Adalimumab on Work Status and Work Productivity of Patients with Ankylosing Spondylitis
Maksymowych, W. P., Gooch, K. L., Wong, R. L., Küpper, H., & van der Heijde, D. M. F. M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090242 · Cited by 91
Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last
Berre, C. L., Ricciuto, A., Peyrin‐Biroulet, L., & Turner, D. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.076 · Cited by 81
Chronic Pancreatitis and Its Effect on Employment and Health Care Experience
Gardner, T. B., Kennedy, A. T., Gelrud, A., Banks, P. A., Vege, S. S., Gordon, S. R., & Lacy, B. E. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c5c693 · Cited by 79
Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study
Gisbert, J. P., Cooper, A., Karagiannis, D., Hatlebakk, J. G., Agréus, L., Jablonowski, H., & Nuevo, J. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-90 · Cited by 78
Perceived Workplace Health Support is Associated with Employee Productivity
Chen, L., Hannon, P. A., Laing, S. S., Kohn, M., Clark, K., Pritchard, S., & Harris, J. R. (2015) · American Journal of Health Promotion · doi:10.4278/ajhp.131216-quan-645 · Cited by 80
Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
Panaccione, R., Loftus, E. V., Binion, D. G., McHugh, K., Alam, S., Chen, N., Guérette, B., Mulani, P. M., & Chao, J. (2011) · Canadian Journal of Gastroenterology · doi:10.1155/2011/724813 · Cited by 73
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis
Kimball, A. B., Yu, A. P., Signorovitch, J., Xie, J., Tsaneva, M., Gupta, S. R., Bao, Y., & Mulani, P. M. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.10.020 · Cited by 75
Back/joint Pain, Illness Perceptions and Coping are Important Predictors of Quality of Life and Work Productivity in Patients with Inflammatory Bowel Disease: a 12-month Longitudinal Study
van der Have, M., Brakenhoff, L. K. P. M., van Erp, S. J. H., Kaptein, A. A., Leenders, M. B., Scharloo, M., Veenendaal, R. A., van der Heijde, D. M. F. M., Jong, A. E. V. D. M., Hommes, D. W., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju025 · Cited by 74
Certolizumab pegol for the treatment of Crohn’s disease
Schreiber, S. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11413315 · Cited by 74
Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis
Chen, J., Taylor, B. V., Palmer, A. J., Kirk‐Brown, A., van Dijk, P., Simpson, S., Blizzard, L., & van der Mei, I. A. F. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518781971 · Cited by 66
The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan
Liu, G. G., DiBonaventura, M., Yuan, Y., Wagner, J.-S., L'Italien, G. J., Langley, P. C., & Kamae, I. (2012) · Value in Health · doi:10.1016/j.jval.2011.11.012 · Cited by 65
Economic burden and loss of quality of life from dry eye disease in Canada
Chan, C. C., Ziai, S., Myageri, V., Burns, J. G., & Prokopich, C. L. (2021) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2021-000709 · Cited by 67
Determinants of patient-centered financial stress in patients with locally advanced head and neck cancer
de Souza, J. A., Kung, S., O’Connor, J., & Yap, B. J. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.016337 · Cited by 63
Sick leave and disability pension in inflammatory bowel disease: A systematic review
Büsch, K., da Silva, S. A., Holton, M., Rabacow, F. M., Khalili, H., & Ludvigsson, J. F. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.06.006 · Cited by 61
Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA
Bansback, N. J., Zhang, W., Walsh, D. A., Kiely, P. D. W., Williams, R., Guh, D. P., Anis, A., & Young, A. (2011) · Rheumatology · doi:10.1093/rheumatology/ker385 · Cited by 62
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
Louis, E. J., Löfberg, R., Reinisch, W., Camez, A. A., Yang, M., Pollack, P. F., Chen, N., Chao, J., & Mulani, P. M. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.02.017 · Cited by 59
Estimating Productivity Costs in Health Economic Evaluations: A Review of Instruments and Psychometric Evidence
Tang, K. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0209-z · Cited by 68
Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
Marrie, R. A., Graff, L. A., Walker, J. R., Fisk, J. D., Patten, S. B., Hitchon, C. A., Lix, L. M., Bolton, J. M., Sareen, J., Katz, A., et al. (2018) · JMIR Research Protocols · doi:10.2196/resprot.8794 · Cited by 56
Health Related Quality of Life in Common Variable Immunodeficiency
Quinti, I., Di Pietro, C., Martini, H., Pesce, A. M., Lombardi, F., Baumghartner, M., Colantuono, S., Milito, C., & Tabolli, S. (2012) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.3.603 · Cited by 52
Cost Effectiveness of Alternative Imaging Strategies for the Diagnosis of Small-Bowel Crohn's Disease
Levesque, B. G., Cipriano, L. E., Chang, S. L., Lee, K. K., Owens, D. K., & Garber, A. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.10.032 · Cited by 52
Illness Perceptions and Outcomes in Patients with Inflammatory Bowel Disease: Is Coping a Mediator?
van Erp, S. J. H., Brakenhoff, L., Vollmann, M., van der Heijde, D. M. F. M., Veenendaal, R. A., Fidder, H. H., Hommes, D. W., Kaptein, A. A., Jong, A. E. V. D. M., & Scharloo, M. (2016) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9599-y · Cited by 55
Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes
Wylezinski, L. S., Gray, J. D., Polk, J. B., Harmata, A. J., & Spurlock, C. F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040493 · Cited by 50
Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate‐to‐severe Crohn’s disease in the PRECiSE 2 study
Feagan, B. G., Reilly, M. C., Gerlier, L. C., Brabant, Y., Brown, M. C. J., & Schreiber, S. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04303.x · Cited by 48
Self-citation
Randomised non‐inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild‐to‐moderate ulcerative colitis
D’Haens, G., Sandborn, W. J., Zou, G., Stitt, L., Rutgeerts, P. J., Gilgen, D., Jairath, V., Hindryckx, P., Shackelton, L. M., Vandervoort, M. K., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14164 · Cited by 48
Impact of Allergic Contact Dermatitis on the Quality of Life and Work Productivity
Kalboussi, H., Kacem, I., Aroui, H., Maâlel, O. E., Maoua, M., Brahem, A., guedri, S. E., Chatti, S., Ghariani, N. F., & Mrizak, N. (2019) · Dermatology Research and Practice · doi:10.1155/2019/3797536 · Cited by 51
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
Yamamoto, T., Nakase, H., Watanabe, K., Shinzaki, S., Takatsu, N., Fujii, T., Okamoto, R., Matsuoka, K., Yamada, A., Kunisaki, R., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad038 · Cited by 46
Validation of the Italian translation of the Inflammatory Bowel Disease Questionnaire
Ciccocioppo, R., Klersy, C., Russo, M. L., Valli, M., Boccaccio, V., Imbesi, V., Ardizzone, S., Porro, G. B., & Corazza, G. R. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.12.014 · Cited by 47
Productivity loss and productivity loss costs to United States employers due to priority conditions: a systematic review
Rojanasarot, S., Bhattacharyya, S., & Edwards, N. C. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2172282 · Cited by 53
Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab
Feagan, B. G., Sandborn, W. J., Wolf, D. C., Coteur, G., Purcaru, O., Brabant, Y., & Rutgeerts, P. J. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04568.x · Cited by 46
Self-citation
Reduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy
Roger, A., Campillo, E. A., Torres, M. C., Millan, C., Jauregui, I., Mohedano, E., Liñán, S., Verdu, P., Rubira, N., Santaolalla, M., et al. (2016) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-016-0146-9 · Cited by 51
Work productivity and activity impairment in patients with hidradenitis suppurativa: a cross‐sectional study
Yao, Y., Jørgensen, A. R., & Thomsen, S. F. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14706 · Cited by 46
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA
Travis, S. P. L., Feagan, B. G., Peyrin‐Biroulet, L., Panaccione, R., Danese, S., Lazar, A., Robinson, A. M., Petersson, J. H., Pappalardo, B. L., Bereswill, M., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx093 · Cited by 44
Ill health and distraction at work: Costs and drivers for productivity loss
Białowolski, P., McNeely, E., VanderWeele, T. J., & Węziak‐Białowolska, D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230562 · Cited by 51
Voice disorders in the workplace: Productivity in spasmodic dysphonia and the impact of botulinum toxin
Meyer, T. K., Hu, A. C., & Hıllel, A. D. (2013) · The Laryngoscope · doi:10.1002/lary.24292 · Cited by 47
Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease
Bessissow, T., Chao, C., Lemieux, C., Restellini, S., Afif, W., Bitton, A., Lakatos, P. L., & Wild, G. (2019) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_566_18 · Cited by 43
Spotlight on Transition in Patients With Inflammatory Bowel Disease: A Systematic Review
Erös, A., Soós, A., Hegyi, P. J., Szakács, Z., Erőss, B. M., Párniczky, A., Mezősi, E., Rumbus, Z., & Sarlós, P. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz173 · Cited by 43
Effect of Adalimumab on Work Productivity and Indirect Costs in Moderate to Severe Crohn’s Disease: A Meta-Analysis
Binion, D. G., Louis, E. J., Oldenburg, B., Mulani, P. M., Bensimon, A. G., Yang, M., & Chao, J. (2011) · Canadian Journal of Gastroenterology · doi:10.1155/2011/938194 · Cited by 41
A New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire—Crohn's Disease Version
Vergara, M., Montserrat, A., Casellas, F., Villòria, A., Suarez, D. L., Maudsley, M., Gallardo, O., Ricart, E., & Calvet, X. (2011) · Value in Health · doi:10.1016/j.jval.2011.02.1179 · Cited by 40
Caregiver burden and vocational participation among parents of adolescents with CF
Neri, L., Lucidi, V., Catastini, P., Colombo, C., & the LINFA Study Group (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23352 · Cited by 45
Psychometric validation of the work productivity and activity impairment questionnaire in ulcerative colitis: results from a systematic literature review
Yarlas, A. S., Maher, S. M., Bayliss, M. S., Lovley, A., Cappelleri, J. C., & DiBonaventura, M. (2018) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-018-0088-8 · Cited by 40
Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction
Sindt, C. W., & Foulks (2013) · Clinical ophthalmology · doi:10.2147/opth.s35833 · Cited by 39
Impact of Inflammatory Bowel Disease on Disability
Büsch, K., Sonnenberg, A., & Bansback, N. J. (2014) · Current Gastroenterology Reports · doi:10.1007/s11894-014-0414-0 · Cited by 39
Nocturia is more bothersome than daytime LUTS: Results from an Observational, Real-life Practice Database including 8659 European and American LUTS patients
Everaert, K., Anderson, P. E., Wood, R. P., Andersson, F., & Holm-Larsen, T. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13091 · Cited by 39
The impact of rheumatoid arthritis on the burden of disease in urban China
Langley, P. C., Mu, R., Michael Shengtao, W. U., Dong, P., & Tang, B. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.611201 · Cited by 39
Impact of inflammatory bowel diseases on working life: A French nationwide survey
Berre, C. L., Peyrin‐Biroulet, L., Buisson, A., Olympie, A., Ravel, M.-H., Bienenfeld, C., & Gonzalez, F. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.01.024 · Cited by 38
Resource use and societal costs for Crohnʼs disease in Sweden
Mesterton, J., Jönsson, L., Almer, S. H., Befrits, R., Friis–Liby, I., & Lindgren, S. C. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20939 · Cited by 38
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
Panaccione, R., Colombel, J., Travis, S. P. L., Bossuyt, P. J., Baert, F., Vaňásek, T., Danalıoğlu, A., Novacek, G., Armuzzi, A., Reinisch, W., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318256 · Cited by 36
Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data
Nicholas, J. A., Electricwala, B., Lee, L. K., & Johnson, K. M. (2019) · BMC Neurology · doi:10.1186/s12883-019-1495-z · Cited by 36
Anxiety and Depression Mediate the Relationship Between Perceived Workplace Health Support and Presenteeism
Laing, S. S., & Jones, S. M. W. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000880 · Cited by 33
Health, wellbeing and productivity in the workplace: A Britain's Healthiest Company summary report
Hafner, M., Stolk, C. V., Saunders, C., Krapels, J., & Baruch, B. (2015) · RAND Corporation eBooks · doi:10.7249/rr1084 · Cited by 33
Autoimmunity in Crohn's Disease—A Putative Stratification Factor of the Clinical Phenotype
Roggenbuck, D., Reinhold, D., Baumgart, D. C., Schierack, P., Conrad, K., & Laass, M. W. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.06.002 · Cited by 31
Identification of areas of functioning and disability addressed in inflammatory bowel disease-specific patient reported outcome measures
Achleitner, U., Coenen, M., Colombel, J., Peyrin‐Biroulet, L., Sahakyan, N., & Cieza, A. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.11.003 · Cited by 30
Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
Youssef, M., Hossein-Javaheri, N., Hoxha, T., Mallouk, C., & Tandon, P. (2024) · Journal of Crohn's & Colitis · doi:10.1093/ecco-jcc/jjae057 · Cited by 27
Effect of risankizumab on health‐related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE , ADVANCE and FORTIFY clinical trials
Peyrin‐Biroulet, L., Ghosh, S. K., Lee, S. D., Lee, W., Griffith, J. M., Wallace, K. L., Berg, S., Liao, X., Panés, J., Loftus, E. V., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17242 · Cited by 28
Health-Related Quality of Life Impairment and Indirect Cost of Crohn’s Disease: A Self-Report Study in Poland
Holko, P., Kawalec, P., Mossakowska, M., & Pilc, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168586 · Cited by 27
Characterizing the quality-of-life impact of Duchenne muscular dystrophy on caregivers: a case-control investigation
Schwartz, C. E., Stark, R. B., Audhya, I. F., & Gooch, K. L. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00386-y · Cited by 27
Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohnʼs disease version
Vergara, M., Montserrat, A., Casellas, F., Maudsley, M., Gallardo, O., Ricart, E., & Calvet, X. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32830f4c9e · Cited by 24
Construct Validity and Responsiveness of the Single-Item Presenteeism Question in Patients With Lower Back Pain for the Measurement of Presenteeism
Kigozi, J., Lewis, M., Jowett, S. M., Barton, P. M., & Coast, J. (2013) · Spine · doi:10.1097/brs.0000000000000162 · Cited by 25
Burden of disease in patients with a history of status epilepticus and their caregivers
King‐Stephens, D., Wheless, J. W., Krogh, C., Bettles, M., Niemira, J., Stolper, R., Benitez, A., Fournier, M., Spalding, W. M., & Lü, M. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107374 · Cited by 26
Systematic Review of Health-Related Work Outcome Measures and Quality Criteria-Based Evaluations of Their Psychometric Properties
Mateen, B. A., Doogan, C., Hayward, K., Hourihan, S. J., Hurford, J., & Playford, E. D. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.06.013 · Cited by 26
Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and Interventions
Tse, C. S., Hunt, M. G., Brown, L. A., & Lewis, J. D. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad182 · Cited by 23
How Rapidly Should Remission Be Achieved?
Isaacs, K. L. (2010) · Digestive Diseases · doi:10.1159/000320415 · Cited by 23
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry
Loftus, E. V., Reinisch, W., Panaccione, R., Berg, S., Alperovich, G., Bereswill, M., Kalabic, J., Petersson, J. H., Thakkar, R. B., Robinson, A. M., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz008 · Cited by 23
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine
Ford, J. H., Ye, W., Ayer, D. W., Mi, X., Bhandari, S., Buse, D. C., & Lipton, R. B. (2023) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-023-00552-4 · Cited by 24
Linguistic Validation into 20 Languages and Content Validity of the Rheumatoid Arthritis-Specific Work Productivity and Activity Impairment Questionnaire
Lambert, J., Hansen, B. B., Arnould, B., Grataloup, G., Guillemin, I., Højbjerre, L., Strandberg-Larsen, M., & Reilly, M. C. (2014) · Patient · doi:10.1007/s40271-014-0053-4 · Cited by 24
Self-citation
Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients
Benson, M. J., Abelev, S. V., Connor, S. J., Corte, C., Martin, L. J., Gold, L. K., Suraev, A. S., & McGregor, I. S. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa015 · Cited by 21
Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial
Buhl, S. S., Steenholdt, C., Brynskov, J., Thomsen, O. Ø., Bendtzen, K., & Ainsworth, M. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005887 · Cited by 19
Testing the Construct Validity and Responsiveness of the Single-Item Presenteeism Question
Muramatsu, K., Nakao, K. K., Ide, H., & Furui, Y. (2021) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002158 · Cited by 19
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
Panés, J., Loftus, E. V., Higgins, P., Lindsay, J. O., Zhou, W., Yao, X., Ilo, D., Phillips, C. M., Tran, J., González, Y. S., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac260 · Cited by 19
The association of pain with labor force participation, absenteeism, and presenteeism in Spain
Langley, P. C., Molina, J. T., Ferrí, C. M., Hernández, C. P., Varillas, A. T., & Ibán, M. Á. R. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.632045 · Cited by 19
Accommodations and Adaptations to Overcome Workplace Disability in Inflammatory Bowel Disease Patients: A Systematic Review
Paulides, E., Gearry, R. B., de Boer, N. K. H., Mulder, C. J. J., Bernstein, C. N., & McCombie, A. (2018) · Inflammatory Intestinal Diseases · doi:10.1159/000495293 · Cited by 18
Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization
Lytvyak, E., Sutton, R. T., Dieleman, L. A., Peerani, F., Fedorak, R. N., & Kroeker, K. I. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa080 · Cited by 18
Implications of Infliximab Treatment Failure and Influence of Personalized Treatment on Patient-reported Health-related Quality of Life and Productivity Outcomes in Crohn’s Disease
Steenholdt, C., Brynskov, J., Thomsen, O. Ø., Munck, L. K., Christensen, L. A., Pedersen, G., Kjeldsen, J., & Ainsworth, M. A. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv139 · Cited by 18
Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
Parra, R. S., Feitosa, M. R., Ribeiro, L. C. H., Castro, L. D. A., da Rocha, J. J. R., & Féres, O. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/1952086 · Cited by 18
Recruitment of Minority Adolescents and Young Adults Into Randomised Clinical Trials: Testing the Design of the Technology Enhanced Community Health Nursing (Tech-N) Pelvic Inflammatory Disease Trial
Trent, M., Chung, S.-E., Gaydos, C. A., Frick, K. D., Anders, J., Huettner, S., Rothman, R. E., & Butz, A. M. (2016) · EMJ Reproductive Health · doi:10.33590/emjreprohealth/10311621 · Cited by 17
Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn’s Disease or Ulcerative Colitis in the United States
Ding, Z., Muser, E., Izanec, J. L., Lukanova, R., Kershaw, J., & Roughley, A. (2022) · Crohn s & Colitis 360 · doi:10.1093/crocol/otac023 · Cited by 16
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT–Fatigue) in Patients with Crohn’s Disease and Ulcerative Colitis
Loftus, E. V., Ananthakrishnan, A. N., Lee, W., González, Y. S., Fitzgerald, K. A., Wallace, K. L., Zhou, W., Litcher‐Kelly, L., Ollis, S., Su, S., et al. (2023) · PharmacoEconomics - Open · doi:10.1007/s41669-023-00419-w · Cited by 16
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn’s Disease
Ghosh, S. K., Feagan, B. G., Parra, R. S., Lopes, S., Steinlauf, A. F., Kakuta, Y., Joshi, N., Lee, W., Lacerda, A. P., Zhou, Q., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae083 · Cited by 16
Diagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in Europe
Able, S. L., Haynes, V. S., & Hong, J. (2014) · Pragmatic and Observational Research · doi:10.2147/por.s64348 · Cited by 16
Examination of the relationship between disease activity and patient‐reported outcome measures in an inflammatory bowel disease cohort
Jackson, B. D., Con, D., Gorelik, A., Liew, D., Knowles, S. R., & Cruz, P. P. D. (2018) · Internal Medicine Journal · doi:10.1111/imj.13937 · Cited by 17
The impact of follicular (FL) and other indolent non‐Hodgkin's lymphomas (NHL) on work productivity–a preliminary analysis
Cheung, M. C., Imrie, K., Friedlich, J. D., Buckstein, R. J., Lathia, N., & Mittmann, N. (2008) · Psycho-Oncology · doi:10.1002/pon.1404 · Cited by 16
Exploring Work Productivity Loss in Patients With Inflammatory Bowel Disease
Nasr, S., Dahmani, W., Jaziri, H., Hammami, A., Slama, A. B., Ameur, W. B., Elleuch, N., Ksiaa, M., & Jmaa, A. (2023) · Future Science OA · doi:10.2144/fsoa-2022-0034 · Cited by 14
Caregiver Burden in Gastroparesis and GERD: Correlation with Disease Severity, Healthcare Utilization and Work Productivity
Jehangir, A., Collier, A., Shakhatreh, M., Malik, Z., & Parkman, H. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05723-2 · Cited by 13

Authors: Reilly, M. C., Gerlier, L., Brabant, Y., & Brown, M.
ORCID: Gerlier, Laetitia
Venue: Clinical Therapeutics
Publisher: Elsevier BV
Published: 2008-02
Volume: 30
Issue: 2
Pages: 393-404
ISSN: 0149-2918 (ISSN-L)
DOI: 10.1016/j.clinthera.2008.02.016
OpenAlex: W2107743584
Cited by: 196
References: 41
Citations by year: 2026: 7 · 2025: 9 · 2024: 19 · 2023: 16 · 2022: 15 · 2021: 13 · 2020: 14 · 2019: 14 · 2018: 11 · 2017: 3 · 2016: 10 · 2015: 7 · 2014: 13 · 2013: 5 · 2012: 5
FWCI: 6.46
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Clinical Therapeutics (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Keywords: Crohn's disease, Work Productivity and Activity Impairment, labor productivity, activity impairment, absenteeism, presenteeism, disease severity, health-related quality of life, remission, questionnaire validity, responsiveness, inflammatory bowel disease, patient-reported outcomes, standardized response mean, CDAI, IBDQ, EQ-VAS, SF-36
MeSH terms: Absenteeism, Certolizumab Pegol, Activities of Daily Living, Adolescent, Adult, Aged, Crohn Disease, Female, Gastrointestinal Agents, Humans, Immunoglobulin Fab Fragments, Male, Middle Aged, Polyethylene Glycols, Predictive Value of Tests, Quality of Life, Surveys and Questionnaires, Severity of Illness Index, Time Factors, Reproducibility of Results, Treatment Outcome, Cost of Illness, Sick Leave, Young Adult, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks